
HIQA – HTA of Immunisation Against Respiratory Syncytial Virus (RSV) in Ireland
On August 14 HIQA published their rapid assessment of immunisation against respiratory syncytial virus (RSV) in Ireland. The assessment noted the following: The estimated one-year cost of immunising infants for their first RSV season ranged from €3.9 to €19 million depending on the strategy used, and would be partially offset by fewer hospitalisations. The estimated […]






